VivoSim Labs (VIVS) Non Operating Income (2011 - 2026)
VivoSim Labs (VIVS) posted Non Operating Income of $1.4 million for Q2 2026, up 155.26% on a QoQ basis from -$2.6 million in Q1 2026, and up 1877.78% year-over-year from $72000.0 in Q2 2025.
Analysis
VivoSim Labs (VIVS) Non Operating Income (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Non Operating Income for 16 years, with the latest figure at $1.4 million in Q2 2026.
- On a quarterly basis, Non Operating Income rose 1877.78% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was -$1.0 million, a 109.86% decrease from a year earlier, with the FY2026 full-year figure at -$2.4 million, down 123.24% from the prior year.
- Non Operating Income was $1.4 million for Q2 2026 at VivoSim Labs, up from -$2.6 million in the prior quarter.
- The five-year high for Non Operating Income was $10.0 million in Q1 2025, with the low at -$2.6 million in Q1 2026.
- Average Non Operating Income over 5 years is $560722.2, with a median of $65500.0 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income surged 19519.61% in 2025, then slumped 125.75% in 2026.
- Over 5 years, Non Operating Income stood at $95000.0 in 2022, then declined by 20.0% to $76000.0 in 2023, then tumbled by 72.37% to $21000.0 in 2024, then jumped by 180.95% to $59000.0 in 2025, then surged by 2313.56% to $1.4 million in 2026.
- The last three Non Operating Income figures came in at $1.4 million (Q2 2026), -$2.6 million (Q1 2026), and $59000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.84 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | -2.58 Mn |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 10.01 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 169,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |